Literature DB >> 14599117

Prevalence and clinico-epidemiology of familial Graves' disease in Japan based on nationwide epidemiologic survey in 2001.

Takashi Akamizu1, Yosikazu Nakamura, Akiko Tamaoki, Yutaka Inaba, Nobuyuki Amino, Yoshiki Seino.   

Abstract

A nationwide epidemiologic survey of familial Graves' disease (GD) was conducted in 2001. "Familial GD" was defined as a patient who had at least one Graves' patient within the proband's first-degree relatives. The primary survey was performed for estimating the prevalence of patients among a random selection of 2367 departments/hospitals of internal medicine, endocrinology, thyroidology and pediatrics. Of those receiving the primary questionnaire, 1361 (57.5%) responded, and 902 familial GD patients who visited them in 2000 were reported. The total number of patients was estimated to be 2850 (95% confidence intervals: 2100-3600). Based on the nationwide survey concerning the prevalence of hyperthyroidism in 1999, 2.1-3.1% of hyperthyroidism appeared to be familial GD and the relative risk of familial GD was roughly estimated to be 19-42. Subsequently, a second survey was carried out for obtaining the clinicoepidemiologic features of those patients. Of 902 patients, 487 (54%) were reported. No significant differences between familial and non-familial GD were found in age and sex distributions, clinical features or laboratory findings. Familial GD possessed the highest association with Hashimoto's thyroiditis, approximately 8% within the first-degree relatives, suggesting a shared genetic predisposition. These findings confirm the familial clustering of GD in the Japanese population, indicating the importance of environmental factors, genetic factors or both in the development of the disease.

Entities:  

Mesh:

Year:  2003        PMID: 14599117     DOI: 10.1507/endocrj.50.429

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  2 in total

1.  Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases.

Authors:  Toshiki Nakajima; Hajime Yoshifuji; Yoshihisa Yamano; Kimiko Yurugi; Yasuo Miura; Taira Maekawa; Tsuneyasu Yoshida; Hiroshi Handa; Koichiro Ohmura; Tsuneyo Mimori; Chikashi Terao
Journal:  Orphanet J Rare Dis       Date:  2022-05-10       Impact factor: 4.303

Review 2.  Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease.

Authors:  Hidefumi Inaba; Leslie J De Groot; Takashi Akamizu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-23       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.